Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial

This publication has 22 references indexed in Scilit:

• Incidence of testicular germ-cell malignancies in England and Wales: Trends in children compared with adults
  International Journal of Cancer, 1999
• RISING RISK OF TESTICULAR CANCER BY BIRTH COHORT IN THE UNITED STATES FROM 1973 TO 1995
  Journal of Urology, 1999
• Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience.
  Journal of Clinical Oncology, 1998
• Bleomycin in germ cell tumor therapy: not all regimens are created equal.
  Journal of Clinical Oncology, 1997
• Assessment of Risk in Metastatic Testis Carcinoma: Impact on Treatment
  Urologia Internationalis, 1991
• A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
  Journal of Clinical Oncology, 1988
• Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
  New England Journal of Medicine, 1987
• The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)
  British Journal of Cancer, 1983
• The Role of Maintenance Therapy in Disseminated Testicular Cancer
  New England Journal of Medicine, 1981
• Non‐seminoma Germ Cell Tumours (Malignant Teratoma) of the Testis Results of Treatment and an Analysis of Prognostc Factors*
  British Journal of Urology, 1981